Caricamento...
Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
Memantine (3,5-dimethyladamantan-1-amine) is an orally active, noncompetitive N-methyl-D-aspartate receptor (NMDAR) antagonist approved for treatment of moderate-to-severe Alzheimer’s disease (AD), a neurodegenerative condition characterized by a progressive cognitive decline. Unfortunately, memanti...
Salvato in:
| Pubblicato in: | Molecules |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504780/ https://ncbi.nlm.nih.gov/pubmed/32887400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25174005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|